The natriuretic peptide system as a possible therapeutic target for stress-induced obesity

Medical Hypotheses

Volumn 76, Issue 3, 2011, Pages 388-390

  Mutschler, Jochen ^a   Kiefer, Falk ^b  

^a UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE TYPE C;

ARTICLE; BEHAVIOR; BODY WEIGHT; CHRONIC STRESS; DRINKING BEHAVIOR; GENETIC RISK; HORMONE RELEASE; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PROTEIN TARGETING; RISK FACTOR;

ALCOHOL DRINKING; ANIMALS; BODY WEIGHT; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; NATRIURETIC PEPTIDES; OBESITY; PITUITARY-ADRENAL SYSTEM; STRESS, PSYCHOLOGICAL;

EID: 79751525713     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2010.10.049     Document Type: Article

References (44)

1. Haslam D.W., James W.P. Obesity. Lancet 2005, 366:1197-1209.
2. Flegal K.M., Graubard B.I., Williamson D.F., Gail M.H. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 2007, 298:2028-2037.
3. Mann J.N., Thakore J.H. Melancholic depression and abdominal fat distribution: a mini-review. Stress 1999, 3:1-15.
4. Barsh G.S., Farooqi I.S., O'Rahilly S. Genetics of body-weight regulation. Nature 2000, 404:644-651.
5. Adam T.C., Epel E.S. Stress, eating and the reward system. Physiol Behav 2007, 91:449-458.
6. Goldman N., Glei D.A., Seplaki C., Liu I.W., Weinstein M. Perceived stress and physiological dysregulation in older adults. Stress 2005, 8:95-105.
7. Coccurello R., D'Amato F.R., Moles A. Chronic social stress, hedonism and vulnerability to obesity: lessons from rodents. Neurosci Biobehav Rev 2009, 33:537-550.
8. Bartolomucci A., Cabassi A., Govoni P., Ceresini G., Cero C., Berra D., et al. PLoS One 2009, 4:e4331.
9. Bjorntorp P. Do stress reactions cause abdominal obesity and comorbidities?. Obes Rev 2001, 2:73-86.
10. Chrousos G.P., Kino T. Glucocorticoid action networks and complex psychiatric and/or somatic disorders. Stress 2007, 10:213-219.
11. Friedman J.M., Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 1998, 395:763-770.
12. Swanson L.W. Cerebral hemisphere regulation of motivated behavior. Brain Res 2000, 886:113-164.
13. Dallman M.F. Stress-induced obesity and the emotional nervous system. Trends Endocrinol Metab 2010, 21:159-165.
14. Kuhn M. Structure, regulation, and function of mammalian membrane guanylyl cyclase receptors, with a focus on guanylyl cyclase-A. Circ Res 2003, 93:700-709.
15. Ruskoaho H. Atrial natriuretic peptide: synthesis, release, and metabolism. Pharmacol Rev 1992, 44:479-602.
16. Cao L.H., Yang X.L. Natriuretic peptides and their receptors in the central nervous system. Prog Neurobiol 2008, 84:234-248.
17. Herman J.P., Langub M.C., Watson R.E. Localization of C-type natriuretic peptide mRNA in rat hypothalamus. Endocrinology 1993, 133:1903-1906.
18. Herman J.P., Dolgas C.M., Rucker D., Langub M.C. Localization of natriuretic peptide-activated guanylate cyclase mRNAs in the rat brain. J Comp Neurol 1996, 369:165-187.
19. Teunissen C., Steinbusch H., Markerink-van Ittersum M., Koesling D., de Vente J. Presence of soluble and particulate guanylyl cyclase in the same hippocampal astrocytes. Brain Res 2001, 891:206-212.
20. Dallman M.F., Warne J.P., Foster M.T., Pecoraro N.C. Glucocorticoids and insulin both modulate caloric intake through actions on the brain. J Physiol 2007, 583:431-436.
21. Woodard G.E., Rosado J.A. Natriuretic peptides in vascular physiology and pathology. Int Rev Cell Mol Biol 2008, 268:59-93.
22. Mutschler J., Bilbao A., von der Goltz C., Demiralay C., Jahn H., Wiedemann K., et al. Augmented stress-induced alcohol drinking and withdrawal in mice lacking functional natriuretic peptide-A receptors. Alcohol Alcohol 2010, 45:13-16.
23. Landgraf R. Neuropeptides and anxiety-related behavior. Endocr J 2001, 48:517-533.
24. Birkenfeld A.L., Boschmann M., Moro C., Adams F., Heusser K., Franke G., et al. Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans. J Clin Endocrinol Metab 2005, 90:3622-3628.
25. Galitzky J., Sengenes C., Thalamas C., Marques M.A., Senard J.M., Lafontan M., et al. The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men. J Lipid Res 2001, 42:536-544.
26. Rubattu S., Sciarretta S., Valenti V., Stanzione R., Volpe M. Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases. Am J Hypertens 2008, 21:733-741.
27. Miyashita K., Itoh H., Tsujimoto H., Tamura N., Fukunaga Y., Sone M., et al. Natriuretic peptides/cGMP/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity. Diabetes 2009, 58:2880-2892.
28. Bergman R.N., Kim S.P., Hsu I.R., Catalano K.J., Chiu J.D., Kabir M., et al. Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk. Am J Med 2007, 120:S3-8. [discussion S29-32].
29. Wang T.J., Larson M.G., Keyes M.J., Levy D., Benjamin E.J., Vasan R.S. Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals. Circulation 2007, 115:1345-1353.
30. Wang T.J., Larson M.G., Levy D., Benjamin E.J., Leip E.P., Wilson P.W., et al. Impact of obesity on plasma natriuretic peptide levels. Circulation 2004, 109:594-600.
31. Beleigoli A.M., Diniz M.F., Ribeiro A.L. Natriuretic peptides: linking heart and adipose tissue in obesity and related conditions - a systematic review. Obes Rev 2009, 10:617-626.
32. Morley J.E., Farr S.A., Flood J.F. Isatin inhibits food intake in mice. Eur J Pharmacol 1996, 305:23-29.
33. Brewerton T.D., Zealberg J.J., Lydiard R.B., Glover V., Sandler M., Ballenger J.C. CSF isatin is elevated in bulimia nervosa. Biol Psychiatry 1995, 37:481-483.
34. Uehlinger D.E., Zaman T., Weidmann P., Shaw S., Gnadinger M.P. Pressure dependence of atrial natriuretic peptide during norepinephrine infusion in humans. Hypertension 1987, 10:249-253.
35. Fehm H.L., Kern W., Peters A. The selfish brain: competition for energy resources. Prog Brain Res 2006, 153:129-140.
36. Epel E.S., McEwen B., Seeman T., Matthews K., Castellazzo G., Brownell K.D., et al. Stress and body shape: stress-induced cortisol secretion is consistently greater among women with central fat. Psychosom Med 2000, 62:623-632.
37. Kiefer F., Grosshans M. What can addiction research contribute towards the understanding of obesity?. Nervenarzt 2009, 80:1040-1049.
38. Berridge K.C. 'Liking' and 'wanting' food rewards: brain substrates and roles in eating disorders. Physiol Behav 2009, 97:537-550.
39. Volkow N.D., Wang G.J., Fowler J.S., Telang F. Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology. Philos Trans R Soc Lond B Biol Sci 2008, 363:3191-3200.
40. Kiefer F., Wiedemann K. Neuroendocrine pathways of addictive behaviour. Addict Biol 2004, 9:205-212.
41. Vengeliene V., Bilbao A., Molander A., Spanagel R. Neuropharmacology of alcohol addiction. Br J Pharmacol 2008, 154:299-315.
42. Heilig M., Egli M. Pharmacological treatment of alcohol dependence target symptoms and target mechanisms. Pharmacol Ther 2006, 111:855-876.
43. Wiedemann K., Jahn H., Yassouridis A., Kellner M. Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings. Arch Gen Psychiatry 2001, 58:371-377.
44. Wiedemann K., Jahn H., Kellner M. Effects of natriuretic peptides upon hypothalamo-pituitary-adrenocortical system activity and anxiety behaviour. Exp Clin Endocrinol Diabetes 2000, 108:5-13.